Pfect A Solar Barrier Serum Textured

For effective photoprotection, Diethylamino Hydroxybenzoyl Hexyl Benzoate must be applied in sufficient quantities. Clinical standards established by regulatory bodies like the FDA and the European Medicines Agency (EMA) suggest an application density of 2 mg/cm² of skin. For an average adult, this translates to approximately:

• Face and Neck: Approximately 1.25 milliliters (1/4 teaspoon).
• Full Body: Approximately 30 to 35 milliliters (roughly the size of a golf ball or a full shot glass).

• Infants under 6 months: The use of chemical sunscreens like DHHB is generally not recommended unless directed by a pediatrician. Physical barriers (clothing, shade) are preferred.
• Children 6 months and older: DHHB-containing products may be used. Application should be supervised by an adult to ensure even coverage and to prevent accidental ingestion or contact with eyes. The dosage remains the same relative to the surface area of the skin (2 mg/cm²).

Renal Impairment

No dosage adjustment is required for patients with renal impairment, as systemic absorption of topically applied DHHB is negligible.

Hepatic Impairment

No dosage adjustment is required for patients with hepatic impairment due to the lack of systemic circulation and minimal metabolic burden.

Elderly Patients

Elderly patients often have thinner skin (atrophic skin). While this could theoretically increase absorption, studies have not shown a need for dosage modification. However, elderly patients should be monitored for signs of localized skin irritation.

1. 1Preparation: Apply to clean, dry skin. Applying sunscreen to wet skin can dilute the formula and reduce the sun protection factor (SPF).
2. 2Timing: Apply the product at least 15 to 30 minutes before sun exposure. This allows the film-forming agents in the product to set properly on the skin surface.
3. 3Application Technique: Use a "dotting" method to spread the product evenly across all exposed areas. Ensure often-missed spots are covered, including the tops of the ears, the back of the neck, and the tops of the feet.
4. 4Reapplication: This is critical. Reapply every two hours, or more frequently if swimming, sweating heavily, or towel-drying. Even photostable filters like DHHB can be physically rubbed off the skin.
5. 5Storage: Store products in a cool, dry place away from direct sunlight. Excessive heat can cause the emulsion to break, rendering the UV filters less effective.

If you forget to apply DHHB before going outdoors, apply it as soon as you remember. However, be aware that your skin may have already sustained UV damage. Seek shade until the product has had time to set.

Systemic overdose from topical application is virtually impossible. However, accidental ingestion can occur, particularly in children. Signs of ingestion may include gastrointestinal upset, nausea, or vomiting. In case of ingestion, contact a Poison Control Center immediately. If the product gets into the eyes, flush with copious amounts of lukewarm water for at least 15 minutes.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your application frequency or amount without medical guidance, as this may lead to inadequate protection and increased risk of sunburn.

While Diethylamino Hydroxybenzoyl Hexyl Benzoate is generally well-tolerated, some users may experience localized skin reactions. These are typically mild and transient:

• Slight Stinging: A mild, temporary tingling sensation upon application, especially if applied to skin with a compromised barrier (e.g., recently exfoliated skin).
• Erythema (Redness): Mild localized redness that usually subsides within an hour of application.
• Feeling of Heaviness: Depending on the formulation, some users may feel a "filmy" or greasy residue on the skin.

• Contact Dermatitis: A localized rash characterized by itching, small bumps, or redness. This is often a reaction to the vehicle (fragrances or preservatives) rather than the DHHB itself.
• Pruritus (Itching): Persistent itching at the site of application.
• Dryness: Some formulations may cause a slight drying effect on the skin over several days of use.

• Photoallergy: A rare condition where the UV filter reacts with sunlight to cause an allergic response. DHHB is specifically designed to be photostable to minimize this risk, but it remains a theoretical possibility.
• Urticaria (Hives): The sudden appearance of raised, itchy welts.
• Folliculitis: Inflammation of the hair follicles, often caused by occlusive formulations that trap sweat and bacteria.

> Warning: Stop using products containing Diethylamino Hydroxybenzoyl Hexyl Benzoate and call your doctor immediately if you experience any of these.

• Anaphylaxis: While extremely rare for topical UV filters, symptoms include swelling of the face, lips, or tongue, difficulty breathing, and a rapid drop in blood pressure.
• Severe Blistering: If the skin develops painful blisters or begins to peel extensively (beyond a normal sunburn reaction).
• Ocular Chemical Burn: If the product enters the eye and causes severe pain, blurred vision, or persistent redness despite flushing.
• Generalized Body Rash: A rash that spreads beyond the site of application, indicating a systemic allergic sensitivity.

There is currently no clinical evidence suggesting that long-term use of Diethylamino Hydroxybenzoyl Hexyl Benzoate leads to systemic toxicity, hormonal disruption, or organ damage. Because it lacks the estrogenic activity associated with some older filters like Oxybenzone, it is considered safe for daily, long-term use. The primary "effect" of long-term use is the significant reduction in cumulative UV damage and a lower risk of skin malignancies.

No FDA black box warnings have been issued for Diethylamino Hydroxybenzoyl Hexyl Benzoate. It is not classified as a high-risk medication. However, users should always perform a patch test if they have a history of multiple chemical sensitivities.

Report any unusual symptoms or persistent skin changes to your healthcare provider. Monitoring for changes in moles (the ABCDE rule) remains essential even when using high-quality sun protection.

Diethylamino Hydroxybenzoyl Hexyl Benzoate is for external use only. It should never be ingested or applied to mucosal membranes (inside the mouth, nose, or genital area). While it provides significant protection against UVA radiation, no sunscreen provides 100% protection. Users should employ a multi-faceted approach to sun safety, including wearing protective clothing, seeking shade during peak UV hours (10 AM to 4 PM), and wearing UV-rated sunglasses.

There are no FDA black box warnings for Diethylamino Hydroxybenzoyl Hexyl Benzoate. It is widely recognized by international health authorities as having a favorable safety profile for topical application.

• Allergic Reactions: Individuals with a known hypersensitivity to benzoate derivatives should exercise caution. A patch test on a small area of the inner forearm is recommended before widespread use.
• Compromised Skin Barrier: Do not apply to skin that is severely broken, oozing, or infected. The presence of open wounds may increase the risk of localized irritation or, in rare cases, unwanted systemic absorption.
• Eye Irritation: Avoid the periocular area (directly around the eyes). If contact occurs, the surfactants and filters in the product can cause significant stinging and temporary blurred vision.
• Environmental Impact: While DHHB is often cited as being more "reef-friendly" than Oxybenzone, users should check local regulations in sensitive ecological zones (like Hawaii or Palau) regarding permitted sunscreen ingredients.

There are no specific laboratory monitoring requirements (such as blood counts or liver function tests) for patients using DHHB. However, regular dermatological exams are recommended for all individuals, especially those with a history of significant sun exposure or a family history of skin cancer. Patients should self-monitor for any new or changing moles.

Topical application of Diethylamino Hydroxybenzoyl Hexyl Benzoate does not impair the ability to drive or operate heavy machinery. It has no sedative or psychoactive effects.

There are no known interactions between topical DHHB and the consumption of alcohol. However, alcohol consumption can lead to dehydration and may increase the skin's sensitivity to heat, so adequate hydration is advised during sun exposure.

If a skin rash or irritation develops, discontinue use immediately. There is no withdrawal syndrome associated with stopping the use of UV filters. However, stopping use will immediately remove the protective barrier against UVA radiation, increasing the risk of sunburn and long-term skin damage.

> Important: Discuss all your medical conditions, especially inflammatory skin conditions like eczema or psoriasis, with your healthcare provider before starting a new skincare regimen containing Diethylamino Hydroxybenzoyl Hexyl Benzoate.

There are no known drug-drug interactions that are strictly contraindicated with the topical use of Diethylamino Hydroxybenzoyl Hexyl Benzoate. Because it acts as a physical/chemical barrier on the skin surface and does not enter the bloodstream in significant amounts, it does not interfere with systemic medications.

• Topical Retinoids (Tretinoin, Adapalene): Retinoids increase skin cell turnover and can make the skin significantly more sensitive to both UV radiation and topical ingredients. While DHHB is necessary to protect retinoid-treated skin, the combination may occasionally cause increased peeling or stinging. It is often recommended to apply retinoids at night and DHHB-containing products in the morning.
• Benzoyl Peroxide: While not a direct chemical interaction, using high concentrations of benzoyl peroxide for acne alongside certain sunscreen formulations may lead to excessive dryness or irritation.

• Physical Blockers (Zinc Oxide, Titanium Dioxide): DHHB is often formulated with these inorganic filters to provide broad-spectrum protection. This is a positive interaction (synergy), but users should ensure the product is well-mixed to avoid "clumping" of the mineral particles, which can leave gaps in protection.
• Vitamin C (Ascorbic Acid): Applying a Vitamin C serum before DHHB can actually enhance the photoprotective effect by neutralizing free radicals that the UV filter might miss. However, ensure the serum is fully absorbed before applying the sunscreen to prevent pilling.

There are no known interactions between Diethylamino Hydroxybenzoyl Hexyl Benzoate and any foods, including grapefruit, dairy, or high-fat meals. The topical nature of the product precludes any digestive-system-based interactions.

There are no documented interactions between topical DHHB and herbal supplements like St. John's Wort or Ginkgo Biloba. However, some supplements (like St. John's Wort) can cause systemic photosensitivity. If you are taking such supplements, the use of a high-UVA filter like DHHB is even more critical, though you should still consult your doctor about your increased risk of sun reactions.

Diethylamino Hydroxybenzoyl Hexyl Benzoate does not interfere with standard blood, urine, or imaging tests. It does not alter glucose levels, coagulation markers, or liver enzyme panels.

Mechanism of Interactions

Most interactions involving DHHB are pharmacodynamic in nature, occurring on the skin surface. For example, the synergy between DHHB and Ethylhexyl Triazone (a UVB filter) allows for a higher SPF and UVA-PF (UVA Protection Factor) than either could achieve alone. This is managed by cosmetic chemists during the formulation process to ensure stability and efficacy.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, even if they are topical or over-the-counter.

Diethylamino Hydroxybenzoyl Hexyl Benzoate must NEVER be used in the following circumstances:

• Known Hypersensitivity: If you have had a documented allergic reaction (anaphylaxis, severe contact dermatitis) to DHHB or any other benzoate-based compound.
• Ingestion: The product is toxic if swallowed in large quantities and must never be used orally.
• Application to the Eyes: Direct contact with the ocular surface can cause chemical irritation and potential corneal epithelial damage.

Conditions requiring careful risk-benefit analysis and a doctor's consultation include:

• Acute Eczema or Dermatitis Flare-ups: Applying chemical filters to highly inflamed or weeping skin may exacerbate the condition. Physical sunscreens (zinc oxide) may be better tolerated during a flare.
• Post-Laser Resurfacing (Immediate): Immediately after deep laser treatments, the skin barrier is non-existent. Only products specifically approved by the performing surgeon or dermatologist should be used until re-epithelialization occurs.
• Rosacea: Some individuals with rosacea find chemical filters irritating. While DHHB is less irritating than older filters, a trial application is advised.

There is a theoretical risk of cross-sensitivity for individuals allergic to other benzoate esters or certain local anesthetics (like procaine) that share a similar benzoic acid backbone. If you have a known allergy to "caine" anesthetics, discuss this with your dermatologist before using DHHB.

> Important: Your healthcare provider will evaluate your complete medical history, including any history of skin allergies, before prescribing or recommending products containing Diethylamino Hydroxybenzoyl Hexyl Benzoate.

• FDA Pregnancy Category: Not formally assigned (as it is a topical OTC ingredient), but international data (SCCS) suggests it is safe.
• Risk Summary: Animal studies using high oral doses of DHHB have shown no evidence of teratogenicity (birth defects) or reproductive toxicity. Because human systemic absorption is negligible, the risk to the developing fetus is considered extremely low. Many dermatologists consider DHHB a preferred UVA filter during pregnancy compared to Oxybenzone, which has raised concerns regarding endocrine disruption.

• Passage into Milk: It is highly unlikely that DHHB passes into breast milk in any detectable quantity due to its poor systemic absorption.
• Nursing Infant: There are no known risks to the nursing infant. However, breastfeeding mothers should avoid applying the product directly to the nipple or areola area to prevent the infant from accidentally ingesting the product during feeding.

• Approved Age: Generally safe for children over 6 months of age.
• Special Considerations: Children have a higher surface-area-to-body-mass ratio, which can theoretically increase absorption. However, DHHB’s large molecular size makes this a minimal concern. Always use formulations specifically tested for pediatric skin, which are often fragrance-free.

• Skin Integrity: Elderly patients often have thinner skin and may be more prone to localized irritation.
• Polypharmacy: There are no concerns regarding DHHB interacting with the multiple systemic medications often taken by elderly patients.
• Vitamin D: Excessive use of high-UVA/UVB protection can theoretically lead to Vitamin D deficiency in the elderly. Discuss Vitamin D supplementation with your doctor if you practice strict sun avoidance.

No adjustments are needed. The kidneys are not involved in the clearance of topically applied DHHB under normal conditions.

No adjustments are needed. There is no significant hepatic first-pass metabolism for topical applications.

> Important: Special populations, particularly pregnant women and those with chronic skin conditions, require an individualized medical assessment by a healthcare professional.

Diethylamino Hydroxybenzoyl Hexyl Benzoate functions as a chemical UVA filter. At the molecular level, it contains a conjugated system of double bonds within its benzoyl group. This configuration allows the molecule to absorb the energy of UVA photons. The absorbed energy promotes an electron from the Highest Occupied Molecular Orbital (HOMO) to the Lowest Unoccupied Molecular Orbital (LUMO). This energy is then dissipated through a process called "internal conversion," where the electronic energy is converted into vibrational energy (heat) and released to the surrounding environment. This allows the molecule to return to its ground state without undergoing chemical degradation, making it highly photostable.

• Dose-Response: The level of UVA protection (measured by the UVA Protection Factor or PPD) is directly proportional to the concentration of DHHB in the formulation, up to the maximum permitted regulatory limit (usually 10% in the EU).
• Onset: Protection is immediate upon the formation of a uniform film on the skin, though 15-20 minutes is recommended for the film to "set."
• Duration: Protection lasts as long as the film remains intact on the skin, typically up to 2 hours under normal conditions.

| Parameter | Value |

|---|---|

| Bioavailability | < 0.1% (Topical) |

| Protein Binding | N/A (Negligible systemic levels) |

| Half-life | N/A (Not systemically active) |

| Tmax | N/A |

| Metabolism | Minimal (Esterase hydrolysis) |

| Excretion | Physical shedding/washing |

• Molecular Formula: C24H31NO4
• Molecular Weight: 397.5 g/mol
• Solubility: Highly oil-soluble; insoluble in water.
• Structure: It consists of a hexyl ester of 2-(4-diethylamino-2-hydroxybenzoyl)benzoic acid. The amino-substituted hydroxybenzoyl group is responsible for its UV-absorbing properties.

DHHB belongs to the class of Organic UVA Filters. It is often grouped with other "modern" filters like Tinosorb S and Tinosorb M, which are characterized by higher molecular weights and better safety profiles than older "legacy" filters like Oxybenzone or Octocrylene.